ProfileGDS4718 / 230569_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 2% 27% 8% 8% 43% 34% 8% 6% 9% 17% 6% 26% 36% 39% 6% 9% 19% 25% 14% 13% 11% 13% 15% 8% 40% 15% 24% 9% 62% 25% 36% 7% 6% 21% 58% 26% 11% 7% 40% 9% 28% 28% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.675317
GSM549102patient 115, normal, homogenized [OPG study]3.459512
GSM549104patient 119, normal, homogenized [OPG study]4.3891927
GSM549108patient 138, normal, homogenized [OPG study]3.734918
GSM549119patient 077, normal, homogenized [OPG study]3.683318
GSM549133patient 032, cancer, homogenized [OPG study]5.1017843
GSM549139patient 042, cancer, homogenized [OPG study]4.7148734
GSM549099patient 107, normal, homogenized [OPG study]3.706688
GSM549109patient 139, normal, homogenized [OPG study]3.653446
GSM549110patient 046, normal, homogenized [OPG study]3.759439
GSM549114patient 063, normal, homogenized [OPG study]4.0097817
GSM549122patient 082, normal, homogenized [OPG study]3.643786
GSM549134patient 033, cancer, homogenized [OPG study]4.3751326
GSM549136patient 036, cancer, homogenized [OPG study]4.7599136
GSM549140patient 044, cancer, homogenized [OPG study]4.9211339
GSM549111patient 047, normal, homogenized [OPG study]3.608446
GSM549113patient 057, normal, homogenized [OPG study]3.702299
GSM549132patient 031, cancer, homogenized [OPG study]4.1092819
GSM549137patient 038, cancer, homogenized [OPG study]4.3037125
GSM549142patient 047, cancer, homogenized [OPG study]4.0088914
GSM549100patient 110, normal, homogenized [OPG study]3.9088613
GSM549107patient 135, normal, homogenized [OPG study]3.7875911
GSM549115patient 068, normal, homogenized [OPG study]3.8648313
GSM549116patient 072, normal, homogenized [OPG study]3.9395815
GSM549120patient 078, normal, homogenized [OPG study]3.711188
GSM549131patient 030, cancer, homogenized [OPG study]4.9307340
GSM549118patient 074, normal, homogenized [OPG study]3.9656415
GSM549129patient 027, cancer, homogenized [OPG study]4.3254924
GSM549123patient 088, normal, homogenized [OPG study]3.770299
GSM549124patient 006, cancer, homogenized [OPG study]6.2632662
GSM549126patient 015, cancer, homogenized [OPG study]4.3425125
GSM549128patient 025, cancer, homogenized [OPG study]4.7805336
GSM549103patient 117, normal, homogenized [OPG study]3.672337
GSM549117patient 073, normal, homogenized [OPG study]3.633076
GSM549138patient 041, cancer, homogenized [OPG study]4.1660121
GSM549141patient 045, cancer, homogenized [OPG study]5.9983158
GSM549130patient 028, cancer, homogenized [OPG study]4.3839726
GSM549101patient 111, normal, homogenized [OPG study]3.7971911
GSM549105patient 128, normal, homogenized [OPG study]3.656137
GSM549106patient 134, normal, homogenized [OPG study]4.9352240
GSM549112patient 048, normal, homogenized [OPG study]3.742369
GSM549125patient 011, cancer, homogenized [OPG study]4.4594628
GSM549127patient 024, cancer, homogenized [OPG study]4.4388328
GSM549135patient 035, cancer, homogenized [OPG study]5.6128252